Aviv acquires assisted living and skilled nursing facilities for $83.6 million

NewsGuard 100/100 Score

Aviv REIT, Inc. ("Aviv" or the "Company") (NYSE: AVIV) announced today it acquired four post-acute and long-term care skilled nursing facilities ("SNF") in Washington, an assisted living facility ("ALF") in Washington and a campus in Idaho, which includes a SNF and an ALF, for a total price of $83.6 million. The SNF and ALF properties are triple-net leased to existing Aviv operator EmpRes at a blended initial cash yield of 9.0%, for a term of 12 years. EmpRes, which will be Aviv's third largest operator by rent concentration, operates 48 facilities in six states, 23 of which they lease from Aviv. 

"We are pleased with the consistently strong pace of our investment activity, and, as we have anticipated, the depth and quality of the opportunities we are identifying in the market," said Craig M. Bernfield, Chairman and Chief Executive Officer of Aviv. Mr. Bernfield continued, "This investment with EmpRes is further evidence that the commitment and effort we make to support our operator relationships creates ongoing opportunities to invest in off-market transactions in attractive markets all over the country. This transaction increases our third quarter-to-date acquisitions to $182 million and year-to-date acquisitions to $369 million. We look forward to growing our portfolio as attractive opportunities continue to arise with our growth oriented existing operators, such as EmpRes, and with new operator relationships."

Source:

Aviv REIT, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
‘Emergency’ or not, covid is still killing people. Here’s what doctors advise to stay safe.